Gene · 554
NIH grants1,257
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 1,257
Download this page as JSON| Grant | Title | AVPR2 papers | Newest fiscal year |
|---|---|---|---|
| F31HL152563 | New pharmacological tools to explore platelet GPR56 function | 1 | 2022 |
| F32GM137505 | Biased agonsim of CXCL12 stimulation of the atypical and classical receptors, ACKR3 and CXCR4 | 1 | 2022 |
| I01BX000574 | Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth | 1 | 2022 |
| K08DK115901 | Characterization of Novel Signaling Pathways Involved in Water Balance Disorders | 1 | 2022 |
| P01HL084207 | Genetic and Signaling Mechanisms in the Central Regulation of Blood | 1 | 2022 |
| P30DK079337 | UAB-UCSD O'Brien Center for Acute Kidney Injury Research | 1 | 2022 |
| P41GM103493 | A Research Resource for Ultra-sensitive High Throughput Proteomics | 1 | 2022 |
| P50CA062924 | SPORE in Gastrointestinal Cancers | 1 | 2022 |
| R01AG044416 | Treatment of Circadian Disruption from Shiftwork in Older Adults | 1 | 2022 |
| R01AG056944 | Bladder Mucosal Dysfunction During Aging | 1 | 2022 |
| R01AG061105 | A knowledge map to find Alzheimer's disease drugs | 1 | 2022 |
| R01CA121113 | Large-Scale Genetic Analyses of Human Cancer | 1 | 2022 |
| R01CA228216 | Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer | 1 | 2022 |
| R01DC012115 | Implementing genomic medicine in clinical care of deaf patients | 1 | 2022 |
| R01DE019637 | Patterning the Vertebrate Dentition Through Replacement and Repair | 1 | 2022 |
| R01DE026806 | Protease/PAR2/TRPV4 Axis and Oral Cancer Pain | 1 | 2022 |
| R01DK117365 | Role of Skeletal Muscle Health on Poor LIfestyle Related Type 2 Diabetes and Cardiovascular Disease Risk | 1 | 2022 |
| R01DK117913 | The Role of LRG1 in Diabetic Kidney Disease | 1 | 2022 |
| R01DK117914 | A Human Organoid Model of Polycystic Kidney Disease | 1 | 2022 |
| R01DK118019 | The interleukin-1 receptor regulates crosstalk between myeloid and renal tubular cells in hypertension | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/grants?page=17